Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
Condition(s):NeoplasmLast Updated:December 30, 2019Completed
Hide Studies Not Open or Pending
Condition(s):NeoplasmLast Updated:December 30, 2019Completed
Condition(s):Gynecologic CancerLast Updated:January 13, 2021Unknown status
Condition(s):Metastatic Breast CancerLast Updated:October 6, 2023Active, not recruiting
Condition(s):Di George SyndromeLast Updated:February 9, 2021Completed
Condition(s):Solid Tumors; Hematological MalignanciesLast Updated:August 27, 2014Unknown status
Condition(s):Lung CancerLast Updated:February 25, 2016Completed
Condition(s):Sensorineural Hearing Loss; Cytomegalovirus InfectionLast Updated:March 15, 2024Completed
Condition(s):Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous LeukemiaLast Updated:August 10, 2017Completed
Condition(s):Endocrine Tumors; Thyroid Neoplasms; Parathyroid Neoplasms; Adrenal Neoplasm; NeuroblastomaLast Updated:March 21, 2024Recruiting
Condition(s):Rare Diseases; Genetic Predisposition to DiseaseLast Updated:November 29, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.